BiotechTube

Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)

Phase 1/2Completed
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Infertility Implantation Failure

Conditions

Infertility Implantation Failure

Trial Timeline

Sep 1, 2001 → Apr 1, 2002

NCT ID
NCT00504530

About Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)

Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF) is a phase 1/2 stage product being developed by Merck for Infertility Implantation Failure. The current trial status is completed. This product is registered under clinical trial identifier NCT00504530. Target conditions include Infertility Implantation Failure.

What happened to similar drugs?

16 of 20 similar drugs in Infertility Implantation Failure were approved

Approved (16) Terminated (4) Active (4)
✅Crinone + DuphastonMerckApproved
✅FSHMerckApproved
✅CFA + rFSHMerckApproved
✅Gonal-f®MerckApproved
✅HCG + Lupron Trigger + Dual TriggerMerckApproved
✅GONAL f® prefilled pen + GONAL f® prefilled penMerckApproved
✅Gonal-f + Recombinant human chorionic gonadotrophin (r-hCG)MerckApproved

Hype Score Breakdown

Clinical
9
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00504608Phase 1/2Completed
NCT00504530Phase 1/2Completed

Competing Products

20 competing products in Infertility Implantation Failure

See all competitors
ProductCompanyStageHype Score
GenSci094 + Placebo RecFSH / follitropin alfa + Biological: RecFSH / Follitropin alfa (Days 1 to 7) + Placebo GenSci094 + RecFSH / Follitropin alfa (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneSun PharmaceuticalPhase 3
40
Letrozole + Clomiphene citrateSun PharmaceuticalPhase 3
40
Elagolix 200 MG + Leuprolide Acetate 3.75 MG/MLAbbViePhase 1
29
Corifollitropin Alfa + Follitropin beta + oral contraceptive pill pretreatment (Marvelon)MerckPhase 3
40
Crinone + DuphastonMerckApproved
35
Recombinant human follicle stimulating hormone (r-hFSH)MerckPre-clinical
26
hMG + Cetrorelix acetate + Coriogonadotropin alfa + Progesterone gelMerckPhase 3
47
Recombinant human luteinizing hormone (rhLH) + Recombinant follicle-stimulating hormone (rFSH)MerckPhase 2
27
FSHMerckApproved
43
Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)MerckPhase 1/2
32
Pergoveris® + GONAL-f® + Recombinant human chorionic gonadotrophin (r-hCG)MerckPhase 3
40
CFA + rFSHMerckApproved
43
Micronised Progesterone + ProgesteroneMerckPhase 3
40
AS900672-Enriched 50 microgram (mcg) + AS900672-Enriched 100 mcg + AS900672-Enriched 150 mcg + Follitropin alfa 150 international unit (IU) + Recombinant human chorionic gonadotropin (r-hCG)MerckPhase 2
35
gonadotropins plus GnRH antagonists + ganirelixMerckPre-clinical
26
ELONVA + PUREGONMerckPre-clinical
26
Gonalef® (Follitropin alfa) + Purified pituitary gonadotropin (Fertinorm-P®)MerckPhase 3
40
EstrogensMerckPhase 3
40
r-hFSH + r-hLH + u-hCGMerckPhase 2
35
Gonal-f®MerckApproved
35